Torsemide,Furosemide
Not Tagged
['heart failure']
 it looks like this study's primary endpoint was all cause mortality, for a trial testing 2 different loop diuretics? and they powered for a 20% relative risk reduction?! that would be more than double the effect size of sglt-2 inhibitors effects in heart failure for acm.
@TheBHF Intermediate Fellow at @imperialcollege | Honorary Consultant Cardiologist @ImperialNHS | PhD in machine learning in cardiovascular imaging